Theravance Biopharma Inc. (TBPH) was among the biggest gainers on the Russell 2000 for Thursday January 14 as the stock popped 5.22% to $14.10, representing a gain of $0.7 per share. Some 111,319 shares traded hands on 1,103 trades, compared with an average daily volume of 197,658 shares out of a total float of 37.84 million. The stock opened at $13.19 and traded with an intraday range of $14.10 to $12.89.
After today's gains, Theravance Biopharma Inc. reached a market cap of $533.53 million. Theravance Biopharma Inc. has had a trading range between $22.00 and $10.56 over the last year, and it had a 50-day SMA of $16.78 and a 200-day SMA of $14.72.
Theravance Biopharma Inc is engaged in discovery (research), development and commercialization of human therapeutics.
Theravance Biopharma Inc. is based out of Grand Cayman, and has some 287 employees. Its CEO is Rick E. Winningham.
For a complete fundamental analysis analysis of Theravance Biopharma Inc., check out Equities.com’s Stock Valuation Analysis report for TBPH. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.
The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.
For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.